Clinical and experimental evidence indicates that circulating irisin levels are reduced under metabolic stress, including OB and T2DM, with declines correlating with insulin resistance, sarcopenia, and cognitive dysfunction [62,63]. Here, FNDC5 is linked to type 2 diabetes mellitus.